Drugs / Cultured autologous Mesenchymal Cells
Cultured autologous Mesenchymal Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02065167 | Feb 2014 → Jun 2016 | avascular necrosis | Universidad Autonoma de Madrid | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cultured autologous Mesenchymal Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02065167 ↗ |
| Modality | Cell therapy | “cellular therapy derived from bone marrow” NCT02065167 ↗ |
| Route | Other | “minimally invasive surgical implantation of autologous mesenchymal stromal cells” PMID 33535589 ↗ Feb 2021 |